Mimi Tang

From Wikipedia, the free encyclopedia
Mimi Tang
Alma materUniversity of Melbourne
Scientific career
FieldsAllergy immunology
InstitutionsMurdoch Children's Research Institute
Thesis Interleukin-4 and Interferon-Gamma Production in Healthy Nonatopic Children and Children with Atopic Disease  (1994)

Mimi Tang is an Australian immunologist allergist specialized in food oral immunotherapy, such as pairing exposure to peanut proteins with probiotics.[1]

Education[edit]

Tang attended the University of Melbourne for her undergraduate and graduate studies, earning her MBBS in 1986 and PhD in 1995.[2] Her 1994 thesis was titled Interleukin-4 and Interferon-Gamma Production in Healthy Nonatopic Children and Children with Atopic Disease.[3]

Career and research[edit]

Tang has served as the Allergy Translation Director of the Murdoch Children's Research Institute (MCRI) since 2016.[2] That same year, she founded Prota Therapeutics, continuing to serve as its CEO to license food immunotherapies developed at MCRI.[4] Her research has ranged from identifying the immunological pathways of peanut allergies to studying how probiotics containing the bacterial species Lactobacillus rhamnosus can improve one's tolerance to food oral immunotherapy.[5][6] Aside from her traditional research output of journal articles and textbook chapters, Tang co-authored the book Kid's Food Allergies for Dummies, aimed at educating parents on recognizing, managing, and treating food allergies.[7]

Tang is currently on the editorial board for the scientific journals Pediatric Allergy and Immunology, Asian Pacific Journal of Allergy and Immunology, and World Allergy Organization Journal.[8][9][10] She is a member of the anaphylaxis and pediatric committees of the Australasian Society of Clinical Immunology and Allergy (ASCIA), Asia-Pacific Association of Allergology, Asthma, and Clinical Immunology (APAAACI) House of Delegates, World Allergy Organization (WAO) board, and International Union of Immunological Societies (IUIS) Primary Immunodeficiency Expert committee.[11]

References[edit]

  1. ^ "Professor Mimi Tang - Allergies". Murdoch Children's Research Institute. Retrieved 2022-11-28.
  2. ^ a b "Prof Mimi Tang". Murdoch Children's Research Institute. Retrieved 2022-11-28.
  3. ^ Tang, Mimi L. K. (1994). Interleukin-4 and Interferon-Gamma Production in Healthy Nonatopic Children and Children with Atopic Disease. Parkville, Victoria: University of Melbourne.
  4. ^ "Management". Prota Therapeutics. Retrieved 2022-11-28.
  5. ^ Ashley, Sarah E.; Jones, Anya C.; Anderson, Denise; Holt, Patrick G.; Bosco, Anthony; Tang, Mimi L. K. (25 May 2022). "Remission of peanut allergy is associated with rewiring of allergen‐driven T helper 2‐related gene networks". Allergy. 77 (10): 3015–3027. doi:10.1111/all.15324. ISSN 0105-4538. PMC 9790273. PMID 35615783.
  6. ^ Silver, Katie (2017-08-17). "Peanut allergy treatment 'lasts up to four years'". BBC News. Retrieved 2022-11-28.
  7. ^ Tang, Mimi; Allen, Katie (2012). Kid's Food Allergies For Dummies. Wiley. ISBN 9780730308027.
  8. ^ "Editorial Board". Wiley Online Library - Pediatric Allergy and Immunology. 2022.
  9. ^ "Editors". Asian Pacific Journal of Allergy and Immunology. 2022. Retrieved 2022-11-28.
  10. ^ "Editorial Board". World Allergy Organization Journal. 2022. Retrieved 2022-11-28.
  11. ^ "ASCIA Council, Committees and Working Parties". Australasian Society of Clinical Immunology and Allergy (ASCIA). 7 November 2022. Retrieved 2022-11-28.